Management of sleep disorders in fibromyalgia

被引:50
作者
Moldofsky, H [1 ]
机构
[1] Ctr Sleep & Chronobiol, Sleep Disorders Clin, Toronto, ON M5T 3A9, Canada
关键词
D O I
10.1016/S0889-857X(01)00012-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The studies of sleep physiology show that nonrestorative sleep is important in the pathogenesis of fibromyalgia (FM). More than 90% of patients with FM describe disturbed sleep. The sleep is usually perceived to be light and unrefreshing, irrespective of its duration. On the rare occasion that there is a night of restful sleep, the patient often finds that pain and fatigue are substantially improved on the following day. Some patients may be aware of restlessness with kicking and involuntary leg movements, which may delay or disrupt sleep. Sometimes the bed partner may complain that the loud snoring is disturbing his sleep. There may be pauses in the snoring with the appearance of interruptions to breathing during sleep, or the patient may awaken with choking, gasping or a sense of suffocation. Some patients complain of difficulty keeping awake and have uncontrollable sleepiness during the day that is interfering with their social life, work, and their ability to drive safely. This article describes the methods for assessing these various sleep disorders and how they might be managed as part of the comprehensive approach in treating FM patients.
引用
收藏
页码:353 / +
页数:14
相关论文
共 62 条
[1]   Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder [J].
Aaron, LA ;
Burke, MM ;
Buchwald, D .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (02) :221-227
[2]   SLEEP PHYSIOLOGY AND PSYCHOLOGICAL-ASPECTS OF THE FIBROSITIS (FIBROMYALGIA) SYNDROME [J].
ANCH, AM ;
LUE, FA ;
MACLEAN, AW ;
MOLDOFSKY, H .
CANADIAN JOURNAL OF PSYCHOLOGY-REVUE CANADIENNE DE PSYCHOLOGIE, 1991, 45 (02) :179-184
[3]   A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia [J].
Bennett, RM ;
Clark, SC ;
Walczyk, J .
AMERICAN JOURNAL OF MEDICINE, 1998, 104 (03) :227-231
[4]   A COMPARISON OF CYCLOBENZAPRINE AND PLACEBO IN THE MANAGEMENT OF FIBROSITIS - A DOUBLE-BLIND CONTROLLED-STUDY [J].
BENNETT, RM ;
GATTER, RA ;
CAMPBELL, SM ;
ANDREWS, RP ;
CLARK, SR ;
SCAROLA, JA .
ARTHRITIS AND RHEUMATISM, 1988, 31 (12) :1535-1542
[5]  
BRANCO J, 1994, J RHEUMATOL, V21, P1113
[6]  
BURCKHARDT CS, 1994, J RHEUMATOL, V21, P714
[7]   COMPARISON OF AMITRIPTYLINE, CYCLOBENZAPRINE, AND PLACEBO IN THE TREATMENT OF FIBROMYALGIA - A RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL [J].
CARETTE, S ;
BELL, MJ ;
REYNOLDS, WJ ;
HARAOUI, B ;
MCCAIN, GA ;
BYKERK, VP ;
EDWORTHY, SM ;
BARON, M ;
KOEHLER, BE ;
FAM, AG ;
BELLAMY, N ;
GUIMONT, C .
ARTHRITIS AND RHEUMATISM, 1994, 37 (01) :32-40
[8]   SLEEP ELECTROENCEPHALOGRAPHY AND THE CLINICAL-RESPONSE TO AMITRIPTYLINE IN PATIENTS WITH FIBROMYALGIA [J].
CARETTE, S ;
OAKSON, G ;
GUIMONT, C ;
STERIADE, M .
ARTHRITIS AND RHEUMATISM, 1995, 38 (09) :1211-1217
[9]   DOUBLE-BLIND-STUDY OF 5-HYDROXYTRYPTOPHAN VERSUS PLACEBO IN THE TREATMENT OF PRIMARY FIBROMYALGIA SYNDROME [J].
CARUSO, I ;
PUTTINI, PS ;
CAZZOLA, M ;
AZZOLINI, V .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1990, 18 (03) :201-209
[10]   Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability [J].
Cohen, H ;
Neumann, L ;
Shore, M ;
Amir, M ;
Cassuto, Y ;
Buskila, D .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2000, 29 (04) :217-227